News | Magnetic Resonance Imaging (MRI) | June 15, 2020

Canon Medical Receives FDA Clearance for Compressed SPEEDER Technology for 1.5T MR

New software version for Vantage Orian 1.5T also offers cybersecurity solutions to protect patient data

New software version for Vantage Orian 1.5T also offers cybersecurity solutions to protect patient data

June 15, 2020 — Hospitals and institutions are continually looking for ways to improve diagnostic imaging throughput, especially in today’s environment where disinfection of systems and rooms in between patients is crucial. Now, with the newly FDA-cleared Compressed SPEEDER technology for Canon Medical Systems USA, Inc.’s Vantage Orian 1.5T MR system, clinicians can speed up magnetic resonance imaging (MRI) scan times by reconstructing full resolution images from under-sampled data through iterative reconstruction, improving throughput and allowing for substantial time in between exams to help clean or disinfect the scanner if necessary.

Scan times for MRIs have historically been a challenge. To reduce acquisition times, Compressed SPEEDER, also available on the Vantage Galan 3T MR system, supports image acceleration and can be used to avoid unfolding error artifacts sometimes seen with standard parallel imaging, or can achieve higher resolution in 2-D Fast Spin Echo (FSE) acquisitions. Reduced scan times also enhance patient comfort, which in turn may enable higher quality images by mitigating patient movement caused by patient discomfort during long scans.

Compressed SPEEDER is included in an all-new new version of M-Power software available for the Vantage Orian 1.5T, which also comes standard with Windows 10 and embedded cybersecurity solutions from Canon Medical. Patient data is kept secure with continuous patches and updates from Microsoft, as well as whitelisting functions, which give clinicians access only to applications and processes which have been authorized.

“In MR imaging, shortening scan times is vastly important for both the patient and physician. At Canon Medical, our priority is to support our customers and their patients by providing them with timely advancements that can impact their outcomes and workflow,” said Jonathan Furuyama, managing director, MR Business Unit, Canon Medical Systems USA, Inc. “With the help of Compressed SPEEDER along with Windows 10 on the Vantage Orian 1.5T MR system, healthcare providers can offer a quick, comfortable and safe experience for their patients.”

Foe more information: https://us.medical.canon

Related Content

MRI of Nonferromagnetic Ballistics Suspended in Gelatin. 

MRI of Nonferromagnetic Ballistics Suspended in Gelatin. Scout (A), T1-weighted spin-echo (SE) (B), T2-weighted SE (C), T2-weighted gradient-recalled echo (GRE) (TR/TE, 500/10; D), and T2-weighted GRE (TR/TE, 700/30; E) MR images show jacket hollow point .45 automatic Colt pistol bullet (Corbon) (1), solid lead .45 Long Colt bullet (Winchester) (2), full metal jacket (FMJ) automatic Colt pistol bullet (Winchester) (3), 5.56-mm FMJ bullet (Federal Ammunition) (4), #7 lead shotgun pellet (Winchester) (5), and 5-mm lead air gun pellet (Sheridan) (6). On all sequences, metallic artifact is minimal. Although metallic artifact increases or blooms with increased TR/TE in GRE images (D and E), amount of surrounding distortion is still minimal.

News | Magnetic Resonance Imaging (MRI) | January 15, 2021
January 15, 2021 — 
Novel Coronavirus SARS-CoV-2 Transmission electron micrograph of SARS-CoV-2 virus particles, isolated from a patient. Image captured and color-enhanced at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. Credit: National Institute of Allergy and Infectious Diseases, NIH

Novel Coronavirus SARS-CoV-2 Transmission electron micrograph of SARS-CoV-2 virus particles, isolated from a patient. Image captured and color-enhanced at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. Image courtesy of  National Institute of Allergy and Infectious Diseases (NIH)

News | Coronavirus (COVID-19) | January 15, 2021
January 15, 2021 — In one of the first studies to examine the impact of the...
Multidisciplinary functionality supports high-capacity utilization and economic efficiency
News | Mobile C-Arms | January 14, 2021
January 14, 2021 — Siemens Healthineers has announced the Food and Drug Administration (FDA) clearance of the...
Use of telehealth jumped sharply during the first months of the coronavirus pandemic shutdown, with the approach being used more often for behavioral health services than for medical care, according to a new RAND Corporation study.

Getty Images

News | Teleradiology | January 13, 2021
January 13, 2021 — Use of telehealth jumped sha
The U.S. Food and Drug Administration released the agency's first Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) Action Plan. This action plan describes a multi-pronged approach to advance the Agency's oversight of AI/ML-based medical software.
News | Artificial Intelligence | January 12, 2021
January 12, 2021 — The U.S.
Myocarditis among recovering COVID-19 athletes less common than previously reported

Getty Images

News | Cardiac Imaging | January 11, 2021
January 11, 2021 — In a letter published in the December issue of the American Heart Association's...
A study led by researchers at the UCLA Jonsson Comprehensive Cancer Center has found that magnetic resonance imaging, or MRI, frequently underestimates the size of prostate tumors, potentially leading to undertreatment.

A study led by researchers at the UCLA Jonsson Comprehensive Cancer Center has found that magnetic resonance imaging, or MRI, frequently underestimates the size of prostate tumors, potentially leading to undertreatment.

News | Prostate Cancer | January 11, 2021
January 11, 2021 — A study
Jeff Elias, MD, is a neurosurgeon at UVA Health and a pioneer in the field of focused ultrasound.

Jeff Elias, MD, is a neurosurgeon at UVA Health and a pioneer in the field of focused ultrasound. Image courtesy of UVA Health

News | Focused Ultrasound Therapy | January 08, 2021
January 8, 2021 — A scalpel-free alternative to brain surgery has the potential to benefit people with...
The FDA is monitoring the potential impact of viral mutations, including an emerging variant from the United Kingdom known as the B.1.1.7 variant, on authorized SARS-CoV-2 molecular tests

Getty Images

News | Coronavirus (COVID-19) | January 08, 2021
January 8, 2021 — The U.S.